Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention
- PMID: 34177546
- PMCID: PMC8222827
- DOI: 10.3389/fnsyn.2021.660218
Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention
Abstract
Motivational and attentional processes energize action sequences to facilitate evolutionary competition and promote behavioral fitness. Decades of neuropharmacology, electrophysiology and electrochemistry research indicate that the mesocorticolimbic DA pathway modulates both motivation and attention. More recently, it was realized that mesocorticolimbic DA function is tightly regulated by the brain's endocannabinoid system and greatly influenced by exogenous cannabinoids-which have been harnessed by humanity for medicinal, ritualistic, and recreational uses for 12,000 years. Exogenous cannabinoids, like the primary psychoactive component of cannabis, delta-9-tetrahydrocannabinol, produce their effects by acting at binding sites for naturally occurring endocannabinoids. The brain's endocannabinoid system consists of two G-protein coupled receptors, endogenous lipid ligands for these receptor targets, and several synthetic and metabolic enzymes involved in their production and degradation. Emerging evidence indicates that the endocannabinoid 2-arachidonoylglycerol is necessary to observe concurrent increases in DA release and motivated behavior. And the historical pharmacology literature indicates a role for cannabinoid signaling in both motivational and attentional processes. While both types of behaviors have been scrutinized under manipulation by either DA or cannabinoid agents, there is considerably less insight into prospective interactions between these two important signaling systems. This review attempts to summate the relevance of cannabinoid modulation of DA release during operant tasks designed to investigate either motivational or attentional control of behavior. We first describe how cannabinoids influence DA release and goal-directed action under a variety of reinforcement contingencies. Then we consider the role that endocannabinoids might play in switching an animal's motivation from a goal-directed action to the search for an alternative outcome, in addition to the formation of long-term habits. Finally, dissociable features of attentional behavior using both the 5-choice serial reaction time task and the attentional set-shifting task are discussed along with their distinct influences by DA and cannabinoids. We end with discussing potential targets for further research regarding DA-cannabinoid interactions within key substrates involved in motivation and attention.
Keywords: adjunctive; attention; cannabinoids; dopamine; habit; motivation; reinforcement; timing.
Copyright © 2021 Oleson, Hamilton and Gomez.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110031. doi: 10.1016/j.pnpbp.2020.110031. Epub 2020 Jul 12. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32663486 Review.
-
Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans.J Neurosci. 2019 May 22;39(21):4142-4152. doi: 10.1523/JNEUROSCI.2371-18.2019. Epub 2019 Mar 18. J Neurosci. 2019. PMID: 30886012 Free PMC article.
-
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues.Front Psychiatry. 2014 Sep 1;5:118. doi: 10.3389/fpsyt.2014.00118. eCollection 2014. Front Psychiatry. 2014. PMID: 25225488 Free PMC article. Review.
-
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908. CNS Neurol Disord Drug Targets. 2017. PMID: 28240187 Review.
-
Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.Behav Brain Res. 2002 Dec 2;137(1-2):3-25. doi: 10.1016/s0166-4328(02)00282-6. Behav Brain Res. 2002. PMID: 12445713 Review.
Cited by
-
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation.Front Behav Neurosci. 2023 Mar 16;17:1137957. doi: 10.3389/fnbeh.2023.1137957. eCollection 2023. Front Behav Neurosci. 2023. PMID: 37009000 Free PMC article. Review.
-
Characterization of Gαs and Gαolf activation by catechol and non-catechol dopamine D1 receptor agonists.iScience. 2025 Apr 3;28(5):112345. doi: 10.1016/j.isci.2025.112345. eCollection 2025 May 16. iScience. 2025. PMID: 40384932 Free PMC article.
-
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.J Clin Med. 2022 Jan 22;11(3):558. doi: 10.3390/jcm11030558. J Clin Med. 2022. PMID: 35160010 Free PMC article. Review.
-
Local activation of CB1 receptors by synthetic and endogenous cannabinoids dampens burst firing mode of reticular thalamic nucleus neurons in rats under ketamine anesthesia.Exp Brain Res. 2024 Sep;242(9):2137-2157. doi: 10.1007/s00221-024-06889-6. Epub 2024 Jul 9. Exp Brain Res. 2024. PMID: 38980339
-
Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the CNR1 Gene and Dermatoglyphics.Biomedicines. 2024 Oct 7;12(10):2270. doi: 10.3390/biomedicines12102270. Biomedicines. 2024. PMID: 39457583 Free PMC article.
References
-
- Adams C. D., Dickinson A. (1981). Instrumental responding following reinforcer devaluation. Q. J. Exper. Psychol. Sec. B 33 109–121. 10.1080/14640748108400816 - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources